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Abstract
This paper introduces the R package meta4diag for implementing Bayesian
bivariate meta-analyses of diagnostic test studies. Our package meta4diag is a
purpose-built front end of the R package INLA. While INLA offers full Bayesian
inference for the large set of latent Gaussian models using integrated nested Laplace
approximations, meta4diag extracts the features needed for bivariate meta-analysis
and presents them in an intuitive way. It allows the user a straightforward model-
specification and offers user-specific prior distributions. Further, the newly proposed
penalised complexity prior framework is supported, which builds on prior intuitions
about the behaviours of the variance and correlation parameters. Accurate posterior
marginal distributions for sensitivity and specificity as well as all hyperparameters,
and covariates are directly obtained without Markov chain Monte Carlo sampling.
Further, univariate estimates of interest, such as odds ratios, as well as the SROC
curve and other common graphics are directly available for interpretation. An in-
teractive graphical user interface provides the user with the full functionality of the
package without requiring any R programming. The package is available through
CRAN https://cran.r-project.org/web/packages/meta4diag/ and its usage
will be illustrated using three real data examples.
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1 Introduction
A meta-analysis summarises the results from multiple studies with the purpose of finding
a general trend across the studies. It plays a central role in several scientific areas, such
as medicine, pharmacology, epidemiology, education, psychology, criminology and ecology
(Borenstein et al., 2011). A bivariate meta-analysis of diagnostic test studies is a special
type of meta-analysis that summarises the results from separately performed diagnostic
test studies while keeping the two-dimensionality of the data (Van Houwelingen et al.,
2002; Reitsma et al., 2005). Results of a diagnostic test study are commonly provided
as a two-by-two table, which is a cross tabulation including four numbers: the number
of patients tested positive that are indeed diseased (according to some gold standard),
those tested positive that are not diseased, those tested negative that are however diseased
and finally those tested negative that are indeed not diseased. Usually the table entries
are referred to as true positives (TP), false positives (FP), false negatives (FN) and true
negatives (TN), respectively. Those entries are used to compute pairs of sensitivity and
specificity indicating the quality of the respective diagnostic test. The main goal of a
bivariate meta-analysis is to derive summary estimates of sensitivity and specificity from
several separately performed test studies. For this purpose pairs of sensitivity and speci-
ficity are jointly analysed and the inherent correlation between them is incorporated using
a random effects approach (Reitsma et al., 2005; Chu and Cole, 2006). Related accuracy
measures, such as likelihood ratios (LRs), which indicate the discriminatory performance
of positive and negative tests, LR+ and LR− respectively, can be also derived. Further,
frequently used estimates include diagnostics odds ratios (DORs) illustrating the effec-
tiveness of the test or risk differences which are related to the Youden index (Altman,
1990; Youden, 1950).
Reitsma et al. (2005) proposed to model logit sensitivity and logit specificity using a
bivariate normal likelihood, whereby the mean vector itself is modelled using a bivariate
normal distribution (normal-normal model). Our new package meta4diag follows the
approach proposed by Chu and Cole (2006) and Hamza et al. (2008) using an exact
binomial likelihood (binomial-normal model), which has been shown to outperform the
approximate normal likelihood in terms of bias, mean-squared error (MSE) and coverage.
Furthermore, it does not require a continuity correction for zero cells in the two-by-
two table (Harbord et al., 2007). Recently, Chen et al. (2011) and Kuss et al. (2014)
proposed a third alternative, the beta-binomial model, where sensitivity and specificity
are not modelled after the logit transformation but on the original scale using a beta
distribution. The inherent correlation is then incorporated via copulas (Kuss et al., 2014).
In the absence of covariates or in the case that all covariates affect both sensitivity and
specificity (Harbord et al., 2007), the binomial-normal model can be reparameterised into
the hierarchical summary receiver operating characteristic (HSROC) model (Rutter and
Gatsonis, 2001; Harbord et al., 2007). In contrast to the binomial-normal model the
HSROC model uses a scale parameter and an accuracy parameter, which are functions of
sensitivity and specificity and defines an underlying hierarchical SROC (summary receiver
operating characteristic) curve.
Different statistical software environments, such as SAS software (SAS Institute Inc.,
2003), Stata (StataCorp, 2011) and R (R Core Team, 2015), have been used in the past
ten years to conduct bivariate meta-analysis of diagnostic test studies. Within a frequen-
tist setting the SAS PROC MIXED routine and PROC NLMIXED routine can be used to fit
the normal-normal and binomial-normal model, see for example Van Houwelingen et al.
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(2002); Arends et al. (2008); Hamza et al. (2009). The SAS macro METADAS provides a
user-friendly interface for the binomial-normal model and the HSROC model (Takwoingi
and Deeks, 2008). Within Stata the module metandi fits the normal-normal model using
an adaptive quadrature (Harbord and Whiting, 2009), while the module mvmeta performs
maximum likelihood estimation of multivariate random-effects models using a Newton-
Raphson procedure (White, 2009; Gasparrini et al., 2012). The R package mada (Doebler,
2015; Doebler and Holling, 2012), a specialised version of mvmeta, is specifically designed
for the analysis of diagnostic accuracy. The package provides both univariate modelling
of log odds ratios and bivariate binomial-normal modelling of sensitivity and specificity.
A continuity correction is used for zero cells in the two-by-two tables.
Since the number of studies involved in a meta-analysis of diagnostic tests commonly
is small, often less than 20 studies, and data within each two-by-two table can be sparse,
the use of numerical algorithms for maximising the likelihood of the above complex bi-
variate model might be problematic and lead to non-convergence (Paul et al., 2010).
Bayesian inference that introduces prior information for the variance and correlation pa-
rameters in the bivariate term is therefore attractive (Harbord, 2011). Markov chain
Monte Carlo (MCMC) algorithms can be implemented through the generic frameworks
WinBUGS (Lunn et al., 2000), OpenBUGS (Lunn et al., 2009) or JAGS (Plummer et al.,
2003). There exist further specialised R-packages for analysing diagnostic test studies in
Bayesian setting, such as bamdit or HSROC (Verde, 2015; Schiller and Dendukuri, 2015).
Instead of modelling the link-transformed sensitivity and specificity directly, the package
bamdit models the differences (Di) and sums (Si) of the link-transformed sensitivity and
specificity jointly. The quantities Di and Si are roughly independent by using these linear
transformations, so that Verde (2010) used a zero centered prior for the correlation of
Di and Si to represent vague prior information. Consequently, JAGS is used for model
estimation. In contrast, HSROC builds on the HSROC model to jointly analyse sensitiv-
ity and specificity with and without a gold standard reference test. Uniform priors on a
restricted interval are thereby assumed for all the hyperparameters and model estimation
is carried out using a Gibbs sampler (Chen and Peace, 2013, chapter 10). However, the
use of Bayesian approaches is still limited in practice which might be partly caused by the
fact that many applied scientists feel not comfortable with using MCMC sampling-based
procedures (Harbord, 2011). Implementation needs to be performed carefully to ensure
mixing and convergence. Furthermore, MCMC based methods are often time consuming,
in particular, when interest lies in simulation studies which require several MCMC runs.
Paul et al. (2010) proposed to perform full Bayesian inference using integrated nested
Laplace approximations (INLA) which avoids MCMC entirely (Rue et al., 2009). The R-
package INLA, see www.r-inla.org, implements Bayesian inference using INLA for the
large set of latent Gaussian models. However, we understand that the range of options
and the required knowledge of available features in INLA might be overwhelming for the
applied user interested in only one specific model. Here, we present a new R package
meta4diag which is a purpose-built package defined on top of INLA extracting only the
features needed for bivariate meta regression. Our package meta4diag implements the
binomial-normal model. Model definition is straightforward, and output statistics and
graphics of interest are directly available. Therefore, users do not need to know the
structure of the general INLA output object. Although its greatest strength, another
criticism towards Bayesian inference is the choice of prior distributions. Our package
meta4diag allows the user to specify prior distributions for the hyperparameters using
intuitive statements based on the recently proposed framework of penalised complexity
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(PC) priors (Simpson et al., 2014). Alternatively, standard prior distributions or user-
specific prior distributions can be used. Our package is appealing for routine use and
applicable without any deep knowledge of the programming language R via the integrated
Graphical User Interface (GUI) offering roll-down menus and dialog boxes implemented
using the R package shiny (RStudio, Inc, 2013).
The rest of this paper is organised as follows. In Section 2 we introduce the binomial-
normal model and discuss its estimation within a Bayesian inference setting. Here, specific
emphasis is given on the definition of prior distributions. Section 3 illustrates the func-
tionality of the package meta4diag. Model output and available graphics are described
based on the previously analysed Telomerase (Glas et al., 2003), Scheidler (Scheidler
et al., 1997) and Catheter (Chu et al., 2010) datasets. Further, the user-friendly GUI is
presented. Finally, a conclusion is given in Section 4.
2 Introducing the statistical framework
2.1 Binomial-normal model for bivariate meta-analysis
In a bivariate meta-analysis, each study presents the number of true positives (TP), false
positives (FP), true negatives (TN), and false negatives (FN). Let Se = TP/(TP + FN)
denote the true positive rate (TPR) which is known as sensitivity and Sp = TN/(TN+FP)
the true negative rate (TNR) which is known as specificity. Chu and Cole (2006) proposed
the following bivariate generalised linear mixed effects model to summarise the results of
several diagnostic studies, i = 1, . . . , I, by modelling sensitivity and specificity jointly:
TPi|Sei ∼ Binomial(TPi + FNi, Sei), logit(Sei) = µ+ Uiα+ φi,
TNi|Spi ∼ Binomial(TNi + FPi, Spi), logit(Spi) = ν + Viβ + ψi,(
φi
ψi
)
∼ N
[(
0
0
)
,
(
σ2φ ρσφσψ
ρσφσψ σ
2
ψ
)]
.
(1)
Here, µ, ν denote the intercepts for logit(Sei) and logit(Spi), respectively, and Ui, Vi
study-level covariates vectors with corresponding coefficient parameters α and β. The
covariance matrix of the random effects φi and ψi is parameterised using between-study
variances σ2φ, σ
2
ψ and correlation ρ.
The most-commonly-used logit link function can be replaced by other monotone link
functions, such as the probit or the complementary log-log transformation. We assume
that both sensitivity and specificity are modelled with the same link function. If desired,
model (1) can easily be changed to model sensitivity and the false positive rate (1− Sp),
or the false negative rate (1−Se) and specificity, or 1−Se and 1−Sp, instead of sensitivity
and specificity, causing the corresponding change in parameter estimates. Different model
options are available through the argument model.type in the package meta4diag, see
Section 3.3.
2.2 Specification of prior distributions
We specify prior distributions for all parameters, i.e., the three hyperparameters σ2φ, σ
2
ψ
and ρ, as well as the fixed effects µ, ν, α and β. Per default a normal prior with zero
mean and large variance is used for the fixed effects µ, ν, α and β. The user is free to
specify any prior distribution for σ2φ, σ
2
ψ and ρ including the newly proposed penalised
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complexity (PC) priors, see Simpson et al. (2014) for details. One of the four principles
underlying PC priors is Occam’s razor. The idea is to see a certain model component as
a flexible extension of a base model (commonly a simpler model) to which we would like
to reduce if not otherwise indicated by the data. Thinking of a Gaussian random effect
with mean zero and covariance matrix σ2I, the base model would be σ2 = 0, i.e., the
absence of the effect. A PC prior puts maximum density mass at the base model and
decreasing mass with increasing distance away from the base model. The PC prior for
the variance components σ2φ or σ
2
ψ is discussed in Simpson et al. (2014, Section 2.3) and
corresponds to an exponential prior with parameter λ for the standard deviation σφ or
σψ, respectively. A simple choice to set λ is to provide (u, a) such that P (σ > u) = a
leading to λ = − log(u)/a with u > 0 and 0 < a < 1. Figure 1 shows an example of
the PC prior for the variance. In practice, the PC prior for the variance parameter in a
diagnostic meta-analysis could be derived from the belief of the interval that sensitivities
or specificities lie in. For example, choosing the contrast P(σ > 3) = 0.05 corresponds to
believing that the sensitivities or specificities lie in the interval [0.5, 0.95] with probability
0.95 (Wakefield, 2007).
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Figure 1: An example of the PC prior for the variance calibrated such that P (σ > 1) =
0.05. The black line is the prior density and the shaded area denotes the density weight
a = 0.05 when the standard deviation is larger than u = 1.
For the correlation parameter ρ, Harbord (2011) proposed to use a stronger prior than
the normal prior for the Fisher’s z-transformed correlation, which was used in Paul et al.
(2010). Motivated by the nature of diagnostic tests he proposed to use a prior which is not
centred around zero but defined around some (negative) base value ρ0 instead (Reitsma
et al., 2005). Using the PC prior framework the above suggestions can be implemented
directly. Simpson et al. (2014, Appendix A.3) derives the PC-prior for the correlation
parameter in an autoregressive model of first order assuming the base model being defined
at ρ0 = 0 and identical statistical behaviour left and right of 0. Although slightly tedious,
this derivation can be generalised to an arbitrary ρ0 and asymmetrical behaviour to the
left and right of ρ0 (Guo et al., 2015). Within meta4diag() we offer three strategies
to intuitively define a PC-prior for ρ given an arbitrary value of ρ0. Similar as for the
variance, probability contrasts are used to define the prior intuitively.
Strategy 1: Specify the left tail behaviour and the probability mass on the left-hand
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side of ρ0 by,
P (ρ < u1|ρ0) = a1 and P (ρ < ρ0) = ω.
Here, (ρ0, ω, u1, a1) are the hyperparameters needed to define the prior density.
Strategy 2: Specify the right tail behaviour and the probability mass on the left-hand
side of ρ0 by,
P (ρ > u2|ρ0) = a2 and P (ρ < ρ0) = ω.
Here, (ρ0, ω, u2, a2) are the hyperparameters needed to define the prior density.
Strategy 3: Specify left and right tail behaviours, by
P (ρ < u1|ρ0) = a1 and P (ρ > u2|ρ0) = a2.
Here, (ρ0, u1, a1, u2, a2) are the hyperparameters needed to define the prior density.
Figure 2 shows examples of the PC prior for the correlation using the three different
strategies. The prior density used in Paul et al. (2010) is shown as the gray dashed lines
for comparison. The parameters for the strategies are motivated based on the estimations
results from Menke (2014), who analysed 50 independent bivariate meta-analyses which
were selected randomly from the literature within a Bayesian setting, and Diaz (2015),
who reported frequentist estimates based on a literature review of 61 bivariate meta-
analyses of diagnostic accuracy published in 2010. According to these two publications,
the distribution of the correlation seems asymmetric around zero. We find that around
half of the correlation point estimates are negative, with a mode around −0.2. Only
a small proportion are larger than 0.4 and values larger than 0.8 are rare. Based on
these findings, we choose three differently behaved PC priors that are all defined around
ρ0 = −0.2.
Defining the parameters of the prior distributions based on probability contrasts seems
very intuitive. As illustrated it is straightforward to incorporate available prior knowledge
into the prior distributions, while still have the option to define vague priors using less
stringent probability contrasts. Although we recommend to specify priors for the variance
and correlation components separately, our package also offers the option to use an inverse
Wishart distribution as a prior for the entire covariance matrix.
3 Using package meta4diag
3.1 Package overview
The meta4diag package provides functions for fitting bivariate meta-analyses within a
full Bayesian setting as outlined in Section 2. The package is available via CRAN https:
//cran.r-project.org/web/packages/meta4diag/ and can be directly installed in R
by typing
R> install.packages("meta4diag")
(given a working internet connection and the appropriate access rights on the com-
puter). Within this paper we use package version 2.0.5 and INLA version 0.0-1466099681.
Of note, meta4diag requires INLA to be installed, which can be done using
R> install.packages("INLA", repos = "http://www.math.ntnu.no/inla/R/testing").
Once the package and its dependencies are installed all analyses presented throughout
this work are reproducible.
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Figure 2: Illustration of potential PC priors for the correlation parameter ρ. The black
solid line shows the PC prior and the dashed gray line shows the prior density proposed
by Paul et al. (2010). In all plots we use ρ0 = −0.2. (a) Strategy 1: Prior derived using
P (ρ < −0.8|ρ0 = −0.2) = 0.1 and P (ρ < −0.2) = 0.4; (b) Strategy 2: Prior derived using
P (ρ > 0.8|ρ0 = −0.2) = 0.1 and P (ρ < −0.2) = 0.4; (c) Strategy 3: Prior derived using
P (ρ < −0.8|ρ0 = −0.2) = 0.1 and P (ρ > 0.8|ρ0 = −0.2) = 0.1.
The meta4diag package consists of one major function called meta4diag(). This
function estimates the Bayesian bivariate regression model for diagnostic test studies, as-
suming each study provides TP, FP, TN and FN. Several studies can be grouped according
to a categorical variable. Posterior estimates for parameters of the bivariate model as well
as common plots and summary statistics are directly available. Inference is thereby per-
formed using INLA, which provides accurate deterministic approximations to all model
parameters and linear summary estimates. Based on the output of meta4diag() different
plots of interest can be generated and also non-linear summary estimates, for example the
diagnostics odds ratio (DOR), are available based on Monte-Carlo estimation, whereby
iid samples are generated from the approximated posterior distribution using a built-in
function of INLA.
The package includes three data sets which will be used in the following subsections to
illustrate the functionality of meta4diag. The data sets differ in their structure and the
availability of covariates. The first data set, called Telomerase, was presented by Glas
et al. (2003) and consists of 10 diagnostic test studies. There is no covariate information
available. The low number of studies involved makes this data set challenging when using
maximum likelihood procedures, see for example Riley et al. (2007); Paul et al. (2010).
The second data set, called Scheidler, was presented in Scheidler et al. (1997) and
combines three meta-analyses to compare the utility of three types of diagnostic imaging
procedures to detect lymph node metastases in patients with cervical cancer. The third
data set, called Catheter, consists of 33 studies from a diagnostic accuracy analysis
presented by Chu et al. (2010) and provides disease prevalence as additional covariate.
3.2 General data structure required
The first argument data in the function meta4diag() is the data set. It should be given
as a data frame with a minimum of 4 columns named TP, FP, TN and FN. If there is
no column named studynames providing study names, the meta4diag() function will
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generate an additional column setting the study name indicators to study1, · · · , studyn,
where n is the number of studies in the meta-analysis. Further columns are considered
to be covariates. The data set Telomerase can thus be defined using five columns, where
the first column provides study name indicators and the remaining four provide values of
TP, FP, TN and FN.
R> studynames <- c("Ito_1998", "Rahat_1998", "Kavaler_1998", "Yoshida_1997",
+ "Ramakumar_1999", "Landman_1998", "Kinoshita_1997",
+ "Gelmini_2000", "Cheng_2000", "Cassel_2001")
R> TP <- c(25, 17, 88, 16, 40, 38, 23, 27, 14, 37)
R> FP <- c(1, 3, 16, 3, 1, 6, 0, 2, 3, 22)
R> TN <- c(25, 11, 31, 80, 137, 24, 12, 18, 29, 7)
R> FN <- c(8, 4, 16, 10, 17, 9, 19, 6, 3, 7)
R> Telomerase <- data.frame(studynames = studynames,
+ TP = TP, FP = FP, TN = TN, FN = FN)
R> head(Telomerase)
studynames TP FP TN FN
1 Ito_1998 25 1 25 8
2 Rahat_1998 17 3 11 4
3 Kavaler_1998 88 16 31 16
4 Yoshida_1997 16 3 80 10
5 Ramakumar_1999 40 1 137 17
6 Landman_1998 38 6 24 9
3.3 Analysing a standard meta-analysis without covariate infor-
mation
Here, we show how to analyse the Telomerase data set which represents a meta-analysis
of studies that use the telomerase maker for the analysis of bladder cancer. To analyse
the dataset, we first load the INLA and the meta4diag package in R using
R> library("INLA")
R> library("meta4diag")
We then call the function meta4diag() as follows:
R> res = meta4diag(data = Telomerase, model.type = 1,
+ var.prior = "PC", var2.prior = "PC", cor.prior = "Normal",
+ var.par = c(3, 0.05), cor.par = c(0, 5),
+ link = "logit", nsample = 10000)
The data set is transferred as the first argument followed by the argument model.type
= 1, saying that we would like to model sensitivity and specificity jointly. Of note, the
argument model.type can be any integer from 1 to 4 depending on which two accuracy
measures are going to be modelled. When model.type = 1, sensitivity and specificity
are modelled jointly. The sensitivity and (1-specificity), (1-sensitivity) and specificity
and (1-sensitivity) and (1-specificity) will be jointly modelled when model.type = 2,
model.type = 3 and model.type = 4, respectively. The argument var.prior is a char-
acter string to specify the prior distribution for the (transformed) variance component
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of the first accuracy measure, i.e., here the sensitivity. The options are "PC" for the PC
prior, "Tnormal" for the truncated normal prior, "Hcauchy" for the half-Cauchy prior
and "Unif" for the uniform prior, which are all defined on the standard deviation scale.
Alternatively "Invgamma" for the inverse gamma prior or any user specified prior defined
on the variance scale can be chosen. A user-specified prior for the variance is chosen by
setting var.prior = "Table" and providing a 2-column data frame to var.par. The
first column provides support points for the variance which should be in [0,∞], and the
second column provides the corresponding prior density at these points. Of note, the us-
age of "Table" prior in meta4diag is different from that in INLA. While INLA requires
the user to define the "Table" prior on the internal parameterisation of the hyperparam-
eter, the user of meta4diag can work on the original scale. The argument var2.prior
is a character string to specify the prior distribution for the second variance component.
The options are the same as for the argument var.prior.
The argument cor.prior is a character string defining the prior distribution for the
(transformed) correlation parameter between the two accuracy measures. The options are
"PC" for the PC prior defined on the correlation scale, "Normal" for the normal distribu-
tion defined on the Fisher’s z-transformed correlation, "Beta" for the beta distribution
defined on a suitable transformation, see documentation, and "Table" for an user spe-
cific prior defined on the correlation scale. The "Table" prior for the correlation should
be provided as a 2-column data frame, where the first column provides suitable support
points within [−1, 1], and the second column provides the corresponding density mass of
those points. Alternatively, if at least one of three arguments var.prior, var2.prior
and cor.prior is set to "Invwishart", an inverse Wishart distribution will be used for
the covariance matrix ignoring any other prior definitions for the remaining arguments.
The arguments var.par, var2.par, cor.par are numerical vectors specifying the hyper-
parameters for the priors for variance and correlation parameters. If the inverse Wishart
prior is used the hyperparameters can be set in wishart.par. Prior definitions includ-
ing parameterisations of the different options are given in the package documentation of
meta4diag() or makePriors(). Of note, the arguments var.prior, var2.prior and
cor.prior are not case sensitive, i.e. var.prior="pc" is valid if one uses it to indicate
the PC prior for the first variance component.
Here, we use the logit link function by using link = "logit". Alternative options
are "probit" for the probit link and "cloglog" for the complementary log-log trans-
formation. The argument quantiles requires a numerical vector with values in [0, 1]
defining which posterior quantiles should be returned. The default setting is c(0.025,
0.5, 0.975), and these three quantiles will always be returned. The argument nsample
is an integer specifying the number of iid samples, generated from the approximated pos-
terior distribution, which are used to compute any non-linear function of interest, such as
DOR, LR+ or LR−.
To get summary information for all parameters of the model, we use the function
summary()
R> summary(res)
Time used:
Pre-processing Running inla Post-processing Total
0.1782410 0.1719451 0.2471750 0.5973611
Fixed effects:
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mean sd 0.025quant 0.5quant 0.975quant
mu 1.179 0.198 0.788 1.178 1.577
nu 2.180 0.648 0.942 2.160 3.535
Model hyperpar:
mean sd 0.025quant 0.5quant 0.975quant
var_phi 0.244 0.179 0.050 0.195 0.718
var_psi 3.647 2.070 1.144 3.137 9.071
cor -0.819 0.200 -0.992 -0.888 -0.246
-------------------
mean sd 0.025quant 0.5quant 0.975quant
mean(Se) 0.763 0.030 0.703 0.765 0.818
mean(Sp) 0.887 0.052 0.762 0.896 0.963
-------------------
Correlation between mu and nu is -0.5504.
Marginal log-likelihood: -65.0459
Variable names for marginal plotting:
mu, nu, var1, var2, rho
Here, also the time needed to fit the model as well as the estimated correlation between
the two linear predictors, here µ and ν, is shown. This correlation is different from the
hyperparameter correlation provided in cor, which corresponds to ρˆ, i.e the posterior
correlation between random effects.
To plot the posterior marginal distribution of σ2φ, say, we call the function plot()
with argument var.type = "var1". When defining separate prior distributions for the
variance and correlation parameters and setting overlay.prior = TRUE the prior distri-
bution is shown in the same device. The posterior marginal distributions of σ2φ and σ
2
ψ
together with their corresponding prior distribution are shown in Figure 3. Valid values
of var.type are the names of the fixed effects (i.e., "mu" and "nu" for this dataset),
"var1", "var2" or "rho". The argument save can be set to FALSE (default) to in-
dicate that the resulting figures are not saved on the computer, or to a file name, (e.g.,
"posterior v1.pdf"), to indicate that the plot is saved as "./meta4diagPlot/posterior v1.pdf",
where "./" denotes the current working directory and the directory meta4diagPlot is
created automatically if it does not exist. Alternatively, the argument save can be set to
TRUE to indicate that the plot is saved in the directory meta4diagPlot whereby the name
is chosen according to var.type. Many standard R plotting arguments, such as xlab,
ylab, xlim, ylim and col, can also be set in the plot() function.
R> par(mfrow = c(1, 3))
R> plot(res, var.type = "var1", overlay.prior = T, lwd = 2, save = F)
R> plot(res, var.type = "var2", overlay.prior = T, lwd = 2, save = F)
R> plot(res, var.type = "rho", overlay.prior = T, lwd = 2, save = F)
To get descriptive statistics of study-specific accuracy measures of interest, such as
positive or negative likelihood ratios LR+ or LR−, or the diagnostic odds ratio DOR,
we call the function fitted(). The argument accuracy.type requires a single character
string specifying the statistics of interest. Possible options are besides other "sens"
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Figure 3: Posterior marginals (black solid line) of σ2φ, σ
2
ψ and ρ for the Telomerase data
together with the prior distributions (gray dashed line).
(default), "spec","TPR","TNR","FPR","FNR", "LRpos", "LRneg", "RD", "DOR", "LLRpos",
"LLRneg" and "LDOR" .
R> fitted(res, accuracy.type = "TPR")
Diagnostic accuracies true positive rate (sensitivity):
mean sd 0.025quant 0.5quant 0.975quant
Ito_1998 0.740 0.049 0.634 0.743 0.830
Rahat_1998 0.792 0.047 0.689 0.795 0.876
Kavaler_1998 0.827 0.030 0.766 0.828 0.883
Yoshida_1997 0.692 0.060 0.553 0.699 0.789
Ramakumar_1999 0.688 0.048 0.586 0.690 0.777
Landman_1998 0.794 0.039 0.712 0.796 0.865
Kinoshita_1997 0.623 0.068 0.479 0.627 0.742
Gelmini_2000 0.779 0.045 0.685 0.780 0.862
Cheng_2000 0.770 0.050 0.663 0.772 0.864
Cassel_2001 0.852 0.039 0.765 0.855 0.918
R> fitted(res, accuracy.type = "DOR")
Diagnostic accuracies diagnostic odds ratio (DOR):
mean sd 0.025quant 0.5quant 0.975quant
Ito_1998 68.499 61.320 13.572 51.707 225.479
Rahat_1998 18.770 12.137 4.819 15.924 50.201
Kavaler_1998 10.234 3.715 4.817 9.613 19.309
Yoshida_1997 69.950 41.273 20.087 60.082 174.630
Ramakumar_1999 203.266 186.636 45.031 149.894 692.741
Landman_1998 17.985 8.598 6.745 16.256 39.713
Kinoshita_1997 634.874 5401.401 11.485 130.997 3746.458
Gelmini_2000 34.573 24.859 8.747 28.289 99.020
Cheng_2000 35.889 21.476 10.840 30.989 89.925
Cassel_2001 2.683 1.354 0.885 2.410 5.991
A commonly used graphic to illustrate the results of a meta-analysis is the so-called
forest plot (Lewis and Clarke, 2001). Figure 4 shows the forest plot including 95% credible
intervals for the telomerase data set as obtained using the forest() function.
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R> forest(res, accuracy.type = "sens", est.type = "mean", cut=c(0.4, 1),
+ nameShow = T, ciShow = T, dataShow = "center",
+ text.cex = 1.5, arrow.lwd = 1.5)
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Forest plot for true positive rate (sensitivity)
Figure 4: Forest plot of the true positive rate (sensitivity) for the Telomerase data. Study
names, the given observations (values of TP, FP, TN and FN) as well as model-based mean
estimates within 95% credible intervals are shown. At the bottom a summary estimate
combining all studies is provided. The size of the study specified estimate points () is
proportional to the length of the corresponding credible intervals, the shorter the interval
length the bigger the point and vice versa.
The arguments nameShow, dataShow, estShow require a logical value indicating whether
the study names, the given observations (values of TP, FP, TN and FN) and values of
credible intervals are displayed as texts in the forest plot, respectively. The corresponding
texts are right aligned when the arguments are set to be TRUE. They could also be "left",
"right" or "center" specifying the different alignments. The argument accuracy.type
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is defined as in the fitted() function. The argument est.type requires a character
string specifying the summary estimate to be used. The options are "mean" (default) and
"median". The arguments text.cex specifies the text size, while arrow.lwd specifies the
line width for the credible lines.
The two functions crosshair() and SROC() are available to study the result in the
ROC space with sensitivity on the y-axis and 1-specificity on the x-axis. Figure 5 shows
a crosshair plot displaying the individual studies in ROC space with paired confidence
intervals representing sensitivity and specificity (Phillips et al., 2010). Figure 6 shows
a summary receiver operating characteristic curve (SROC) which is only available when
no separate covariates are included for the two model components, here sensitivity and
specificity, as only then the bivariate meta-regression approach is equivalent to the HSROC
approach (Rutter and Gatsonis, 2001). The corresponding commands are
R> crosshair(res, est.type = "mean", col = c(1:10))
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Figure 5: Crosshair plot for the Telomerase data set. Shown are the posterior means for
each study as the summary points together with paired lines showing the corresponding
95% credible intervals for sensitivity and (1-specificity). Colors are randomly chosen.
R> SROC(res, est.type = "mean", sroc.type = 1,
+ dataShow = "o", crShow = T, prShow = T)
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Figure 6: SROC plot for the Telomerase data set. Each bubble represents one study and
indicates its observed sensitivity and specificity. The size of the bubble is proportional to
the number of individuals in this study. The solid black line is the SROC line. The star
point represents the summary point, the dashed blue line is the 95% credible region and
the dashed gray line is the 95% prediction region.
The argument dataShow specifies whether the original data are shown. The argument
crShow and prShow are Boolean and indicate whether a credible region or prediction
region, respectively, is shown. The argument sroc.type takes an integer value from 1 to
5. When sroc.type=1, the function used to define the SROC line corresponds to “ The
regression line 1” in Arends et al. (2008); Chappell et al. (2009). The values sroc.type=2,
sroc.type=3, sroc.type=4 and sroc.type=5 correspond to “The major axis method”,
“The Moses and Littenberg’s regression line”, “The regression line 2” and “The Rutter
and Gatsonis’s SROC curve”, respectively. Different choices may result in different SROC
lines when the correlation for sensitivity and specificity is positive. We refer to Chappell
et al. (2009) for more details and a comparison of the different formulations.
3.4 Incorporating additional sub-data stratification
The Scheidler data set contains the results of a meta-analysis conducted by Scheidler
et al. (1997) to compare the utility of three types of diagnostic imaging, lymphangiography
(LAG), computed tomography (CT) and magnetic resonance (MRI), to detect lymph node
14
metastases in patients with cervical cancer. The dataset consists of a total of 44 studies:
the first 17 for CT, the following 17 for LAG and the last 10 for MRI. The Scheidler
data set is provided in the package as a data frame with length 44. It has a special column
named “modality” that specifies to which imaging technology, namely CT, LAG or MRI,
each study belongs to. The first five lines of the data set are given as
R> data("Scheidler", package = "meta4diag")
R> head(Scheidler)
studynames modality TP FP FN TN
1 Grumbine_1981 CT 0 1 6 17
2 Walsh_1981 CT 12 3 3 7
3 Brenner_1982 CT 4 1 2 13
4 Villasanta_1983 CT 10 4 3 25
5 vanEngelshoven_1984 CT 3 1 4 12
6 Bandy_1985 CT 9 3 3 29
There are two obvious ways to analyse this data set. First, analyse the meta-analysis
of each imaging technology separately, which gives each study its own estimates of the
hyperparameters. Second, analyse all studies together and incorporate the stratification
using a technology-specific intercept.
To analyse all subdata separately, we call the function meta4diag() three times as-
suming for each subset model (1) without covariate information. Here, we use the default
settings of meta4diag().
R> res.CT = meta4diag(data = Scheidler[Scheidler$modality == "CT", ])
R> res.LAG = meta4diag(data = Scheidler[Scheidler$modality == "LAG", ])
R> res.MRI = meta4diag(data = Scheidler[Scheidler$modality == "MRI", ])
Prior distributions as well as other model details, such as the link function, can be changed
as described in Section 3.3.
To plot the results of all three analyses in one device, we can use the SROC() function
with the argument add=TRUE, see Figure 7a.
R> SROC(res.CT, dataShow = "o", lineShow = T, prShow = F,
+ data.col = "red", cr.col = "red", sp.col = "red")
R> SROC(res.LAG, dataShow = "o", lineShow = T, prShow = F,
+ data.col = "blue", cr.col = "blue", sp.col = "blue", add = T)
R> SROC(res.MRI, dataShow = "o", lineShow = T, prShow = F,
+ data.col = "green", cr.col = "green", sp.col = "green", add = T)
To analyse the entire dataset, we consider the column “modality” as a categorical
covariate and use the following model where the overall intercept is omitted
TPi|Sei ∼ Binomial(TPi + FNi, Sei), logit(Sei) = µi + φi,
TNi|Spi ∼ Binomial(TNi + FPi, Spi), logit(Spi) = νi + ψi,
µi =

µCT if i = 1, . . . , 17
µLAG if i = 18, . . . , 34
µMRI if i = 35, . . . , 44
νi =

νCT if i = 1, . . . , 17
νLAG if i = 18, . . . , 34
νMRI if i = 35, . . . , 44(
φi
ψi
)
∼ N
[(
0
0
)
,
(
σ2φ ρσφσψ
ρσφσψ σ
2
ψ
)]
.
(2)
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Here, i = 1 . . . 44. To analyse this data in meta4diag, we call the function meta4diag()
with argument modality = "modality"
R> res = meta4diag(data = Scheidler, modality = "modality")
R> res
Time used:
Pre-processing Running inla Post-processing Total
0.1231420 0.4855158 0.1479652 0.7566230
Model:Binomial-Normal Bivariate Model for Se & Sp.
Data contains 44 primary studies.
Data has Modality variable with level 3.
Covariates not contained.
Model using link function logit.
Marginals can be plotted with setting variable names to
mu.CT, mu.LAG, mu.MRI, nu.CT, nu.LAG, nu.MRI, var1, var2 and rho.
To print the estimates for the parameters of the model, we use the function summary()
R> summary(res)
Time used:
Pre-processing Running inla Post-processing Total
0.1231420 0.4855158 0.1479652 0.7566230
Fixed effects:
mean sd 0.025quant 0.5quant 0.975quant
mu.CT -0.133 0.271 -0.675 -0.131 0.398
mu.LAG 0.775 0.263 0.262 0.773 1.300
mu.MRI 0.185 0.347 -0.504 0.186 0.869
nu.CT 2.598 0.268 2.074 2.596 3.133
nu.LAG 1.548 0.231 1.098 1.546 2.012
nu.MRI 2.927 0.342 2.255 2.926 3.607
Model hyperpar:
mean sd 0.025quant 0.5quant 0.975quant
var_phi 0.800 0.308 0.353 0.747 1.551
var_psi 0.701 0.258 0.323 0.657 1.327
cor -0.481 0.190 -0.790 -0.500 -0.058
-------------------
mean sd 0.025quant 0.5quant 0.975quant
mean(Se.CT) 0.467 0.057 0.359 0.467 0.575
mean(Se.LAG) 0.682 0.048 0.587 0.684 0.769
mean(Se.MRI) 0.545 0.072 0.405 0.546 0.678
mean(Sp.CT) 0.929 0.015 0.897 0.931 0.954
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mean(Sp.LAG) 0.823 0.028 0.764 0.824 0.873
mean(Sp.MRI) 0.947 0.015 0.915 0.949 0.970
-------------------
Correlation between mu.CT and nu.CT is -0.3013.
Correlation between mu.LAG and nu.LAG is -0.3494.
Correlation between mu.MRI and nu.MRI is -0.3081.
Marginal log-likelihood: -249.7198
Variable names for marginal plotting:
mu.CT, mu.LAG, mu.MRI, nu.CT, nu.LAG, nu.MRI, var1, var2, rho
We apply the SROC() function again to check the difference between a separate and
joint analysis
R> SROC(res, dataShow = "o", lineShow = T, prShow = F,
+ cr.col = c("red", "blue", "green"), sp.col = c("red", "blue", "green"),
+ line.col = c("red", "blue", "green"))
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Figure 7: (a): SROC plot to compare the results for each sub-analysis of the Scheidler
data set. Red: result for CT data. Blue: result for LAG data. Green: result for MRI
data. Bubbles represent the observed values where the size is proportional to the number
of study participants, dashed lines are 95% credible regions and the star points are the
summary points. The lines show the corresponding SROC curves. (b): SROC plot for
the joint analysis of the Scheidler data set. Bubbles are the observations, dashed lines
are 95% credible regions and the star points are the summary points. The lines show the
corresponding SROC curves. Red: result for CT data. Blue: result for LAG data. Green:
result for MRI data.
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Of note the SROC curves strongly vary depending on which formula is used to compute
them, see Chappell et al. (2009) for a discussion. Five different formulas are available in
meta4diag which can be chosen using the argument sroc.type, see Section 3.3 and
documentation.
From Figure 7a and Figure 7b, we can see that the estimated summary points are
almost the same in both analyses. However, the credible regions change slightly using
the different model formulations. More striking are the changes in the SROC curves,
in particular for the LAG subset (blue). Looking at the data there is no obvious trend
that sensitivity increases along with increasing 1−specificity. The estimated posterior
correlation ρˆ is 0.1809[−0.55, 0.79]. Chappell et al. (2009) stated that it is not appropriate
to use SROC curves when ρˆ is close to zero or positive. Using separate analyses, we
assume that each subdata has its own random effect properties. While using the full
data set with a categorical covariate, we assume that all the subdata share the same
covariance matrix. The choice of how to model the data is up to the user. However,
when the argument covariates is used in the modelling, i.e., continuous covariates are
included, the overall summary points, the confidence region and the prediction region are
no longer available through the function SROC(), and only the study specified summary
points can be obtained instead, see the example in Section 3.5.
The corresponding forest plot for this dataset is shown in Figure 8. The plot is
automatically separated into three parts due to the column modality with three different
levels.
R> forest(res, accuracy.type = "sens")
3.5 Use of continuous covariate information
The Catheter Segment Culture data consists of 33 studies from a diagnostic accuracy
analysis by Chu et al. (2010). The studies analysed semi-quantitative (19 studies) and
quantitative (14 studies) catheter segment culture for the diagnosis of intravascular device-
related blood stream infection. In the dataset a column with name type indicates whether
a study is based on semi-quantitative or quantitative catheter segment culture. We con-
sider type as a categorical covariate in the model so that it should be set to modality =
"type". We choose this dataset as an example because it contains an additional column
with name “prevalence” providing disease prevalence information which can be considered
as a continuous covariate. To analyse the dataset, we first load the Catheter dataset
R> data("Catheter", package = "meta4diag")
R> head(Catheter)
studynames type prevalence TP FP TN FN
1 Cooper_1985 Semi-quantitative 3.6 12 29 289 0
2 Gutierrez_1992 Semi-quantitative 12.2 10 14 72 2
3 Cercenado_1990 Semi-quantitative 12.9 17 36 85 1
4 Rello_1991 Semi-quantitative 13.2 13 18 67 0
5 Maki_1977 Semi-quantitative 1.6 4 21 225 0
6 Aufwerber_1991 Semi-quantitative 3.1 15 122 403 2
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Forest plot for true positive rate (sensitivity)
Figure 8: Forest plot for the Scheidler data. The plot is separated into three parts
relating to the three sub-data sets.
Consider that we would like to use the model
FNi|Sei ∼ Binomial(TPi + FNi, Sei), logit(Sei) = µi + α · prevalencei + φi,
TPi|1− Spi ∼ Binomial(TNi + FPi, 1− Spi), logit(1− Spi) = νi + β · prevalencei + ψi,
µi =
{
µsemi-quantitative if i = 1, . . . , 19
µquantitative if i = 20, . . . , 33
νi =
{
νsemi-quantitative if i = 1, . . . , 19
νquantitative if i = 20, . . . , 33(
φi
ψi
)
∼ N
[(
0
0
)
,
(
σ2φ ρσφσψ
ρσφσψ σ
2
ψ
)]
.
(3)
That means we would like to model sensitivity and 1−specificity jointly as proposed
by Chu et al. (2010) for this dataset. This can be done by setting model.type = 2. As
the Catheter Segment Culture data contains one categorical covariate type and one con-
tinuous covariate prevalence, the argument modality is set to be "type" and argument
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covariates is set to be "prevalence".
R> res = meta4diag(data = Catheter, model.type = 2,
+ var.prior = "PC", var2.prior = "PC", cor.prior = "PC",
+ var.par = c(3, 0.05), cor.par = c(1, -0.1, 0.5, -0.95, 0.05, NA, NA),
+ modality = "type", covariates = "prevalence",
+ quantiles = c(0.125, 0.875), nsample = 10000)
Currently only one categorical covariate can be included in the model, whereas there is
no limitation for the number of continuous covariates. In order to include more than one
continuous covariate in the model, the user can provide a vector giving the names of all
covariates to be included or the respective column numbers in the data frame.
Here, we choose a PC prior for all hyperparameters. The vector of parameters for
the PC prior of the correlation parameter must always be of length 7 specifying strategy,
ρ0, ω, u1, α1, u2, α2. However, u2 and α2 are not required when using strategy = 1,
u1 and α1 are not required when strategy = 2 and there is no need to specify ω when
strategy = 3, see Section 2.2. To obtain the 12.5% and 87.5% quantiles in addition
to the default 2.5%, 50% and 97.5% quantiles we set quantiles = c(0.125, 0.875).
Summary estimates are again obtained using the function summary()
R> summary(res)
Time used:
Pre-processing Running inla Post-processing Total
0.4856298 0.7392230 0.1731811 1.3980339
Fixed effects:
mean sd 0.025quant 0.125quant 0.5quant 0.875quant
mu.Semi.quantitative 1.692 0.349 1.032 1.302 1.681 2.089
mu.Quantitative 1.631 0.432 0.806 1.148 1.621 2.121
nu.Semi.quantitative -1.981 0.236 -2.450 -2.249 -1.981 -1.714
nu.Quantitative -2.655 0.316 -3.288 -3.015 -2.652 -2.297
alpha.prevalence 0.007 0.015 -0.023 -0.010 0.007 0.023
beta.prevalence 0.032 0.012 0.008 0.019 0.032 0.046
0.975quant
mu.Semi.quantitative 2.415
mu.Quantitative 2.520
nu.Semi.quantitative -1.517
nu.Quantitative -2.038
alpha.prevalence 0.035
beta.prevalence 0.057
Model hyperpar:
mean sd 0.025quant 0.125quant 0.5quant 0.875quant 0.975quant
var_phi 1.040 0.482 0.390 0.560 0.941 1.575 2.252
var_psi 0.764 0.232 0.415 0.521 0.726 1.031 1.321
cor 0.094 0.216 -0.326 -0.161 0.094 0.349 0.506
Marginal log-likelihood: -239.5213
Variable names for marginal plotting:
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mu.Semi.quantitative, mu.Quantitative, nu.Semi.quantitative,
nu.Quantitative, alpha.prevalence, beta.prevalence, var1, var2, rho
A forest plot for the log diagnostic odds ratio is given in Figure 9. Here, 75% credible
intervals are shown which is specified by setting the argument intervals = c(0.125,
0.875) within the function forest().
R> forest(res, accuracy.type = "LDOR", est.type = "median",
+ nameShow = T, ciShow = "left", dataShow = "center",
+ text.cex = 1.5, arrow.lwd = 1.5,
+ cut = c(0, 10), intervals = c(0.125, 0.875))
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4.35 [ 3.97, 4.72 ]
3.11 [ 2.21, 3.97 ]
4.99 [ 4.09, 6.00 ]
5.24 [ 4.40, 6.20 ]
2.42 [ 1.72, 3.09 ]
3.92 [ 3.23, 4.63 ]
3.81 [ 2.99, 4.69 ]
3.00 [ 2.41, 3.59 ]
2.39 [ 1.74, 3.05 ]
4.70 [ 3.83, 5.62 ]
2.93 [ 2.20, 3.62 ]
3.34 [ 2.54, 4.17 ]
6.20 [ 5.24, 7.27 ]
4.13 [ 3.26, 5.00 ]
Estimates
Forest plot for log diagnostic odds ratio (ldor)
Figure 9: Forest plot for the log diagnostic odds ratio (LDOR) of the Catheter data
set. The study names, original dataset, estimated mean and corresponding 75% credible
intervals are also shown.
Of note, when the argument covariates is available, the summary estimates cannot
be returned through the function forest(). Similarly, the summary points, confidence
region and prediction region in the SROC plot are not available. The SROC curve in
contrast is still available. However, it does not depend on the choice of the argument
sroc.type, but is computed according to Walter (2002) by fitting a regression equation
Di = a+ bSi
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where
Di = log
(
Ŝei
1− Ŝei
)
− log
(
1− Ŝpi
Ŝpi
)
and
Si = log
(
Ŝei
1− Ŝei
)
+ log
(
1− Ŝpi
Ŝpi
)
respectively. After fitting the regression line, the equation of the SROC curve can be
obtained as
SROC(x) =
exp( a
1−b)x
(1+b)/(1−b)
1 + exp( a
1−b)x
(1+b)/(1−b) , x ∈ [0, 1].
3.6 Graphical user interface
To make Bayesian diagnostic meta-analysis easier to use for applied scientists, a cross-
platform, interactive and user-friendly graphical user interface (GUI) has been imple-
mented. The GUI can be used to load the data, set and graphically inspect the priors
as the hyperparameters are manually changed by sliders (see Figure 12), and run the
model. The results of the analysis are shown directly in the interface and can be saved for
later use. The GUI only requires the basic knowledge of R required to start R, load the
libraries and run the command that starts the GUI. Within the interface all options are
visualised as buttons or drop-down menus, and help for each option is found as tooltips
when the user moves the mouse over the option or the “Description area”. The interface
has been tested in the browsers “Internet Explorer”, “Mozilla Firefox”, “Google Chrome”
and “Safari” on Linux, Mac and Windows 10 operating systems.
The GUI is started by loading the libraries meta4diag and INLA and then calling the
function meta4diagGUI() with
R> library("meta4diag")
R> library("INLA")
R> meta4diagGUI()
The start window of the GUI is shown in Figure 10 and is divided into three areas A, B
and C. A contains the toolbar and has buttons for running INLA and writing the results
to a text file, and buttons for starting the tutorial, saving the results to an R object for
further study in R and for quitting the interface. B has 6 tabs that contain the various
control panels, which are used to set up the analysis, such as the data control panel, the
prior control panel, and the model control panel. The options within these three panels
must be set before pressing the “RunINLA” button in A. The “Forest” control panel and
“SROC” control panel in B are used for choosing plotting settings, and can be used both
before and after running the model, and the “Fitted” panel allows the user to inspect
the estimates for different choices of accuracy types and can also be set after running the
model. Lastly, C has 10 tabs where the first is a welcome page and the rest are used to
view the data and the results.
Figure 11, which contains a screenshot of the “Prior Control Panel” on the left-hand
side and the “Model Control Panel” on the right-hand side, gives an example of how the
user can set the model and the prior. The description of the options in each panel is inte-
grated in the GUI through tooltips, but can also be found in the package documentation
(see meta4diag() for details). The left-hand side screenshot only shows how the user can
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Figure 10: GUI main window of meta4diag after start up. (A) toolbar, (B) tool control
panel, (C) view area, showing different pages (welcome message, data set, summary re-
sults, graphics). In particular, the “Data Control Panel” is shown in the “tool control
panel” area. Users could upload their own datasets for analysing or choose a example
dataset for understanding the package. The “Welcome” page is shown in the “view area”.
The basic information for modelling and the description of bivariate meta-analysis of
diagnostic test studies are shown in this page.
set the prior distribution for the first variance component, but the panel also contains
options for setting the priors on the second variance component and the correlation in
the bivariate model. Figure 12 illustrates how the user can explore different settings of
the hyperparameters interactively by sliding the sliders corresponding to each parameter.
When the PC prior is selected for the correlation parameter, the user may use either
of the specification strategies described in Section 2.2 to set the hyperparameters. The
“Model Control Panel” shown on the right-hand side of Figure 11 is used to specify the
model type, link function, quantiles of interest, and more.
After setting the options in the first three control panels and clicking the “RunINLA”
button, the chosen dataset will be loaded and analysed. The results of the analysis will
be shown in the view area (C) and, for example, the SROC plot can be viewed in the
SROC tab of the view area (C) as shown in Figure 13. The other tabs can be used to
view summary estimates, study-specific accuracy estimates, posterior marginal plots and
forest plot, and in each case the R code that generated the figure or text is also shown.
If the data, the model or prior settings are changed, the user must push the “RunINLA”
button again to update the results.
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Figure 11: Details for two tool panels. Left: “Prior Control Panel”. In this panel, users
can set the prior distributions for the first variance component, second variance component
and the correlation. In particular, the specification of the PC-prior for the first variance
component is shown. A “Description area” is shown to explain what the prior is. The
red “Invalid!” indicates that the given value for the hyper parameter α is not valid. The
interval of the valid values can be seen from the tooltips of the indicator “Invalid”. Right:
“Model Control Panel”.
4 Conclusion
The present paper demonstrates the usage of the novel R-package meta4diag for analysing
bivariate meta-analyses of diagnostic test studies with R, and illustrates its usage using
three examples from the literature. The package is built on top of the R-package INLA
and thus provides full Bayesian inference without the need for Markov Chain Monte
Carlo techniques. This is especially important when several or complex meta-analyses
are studied, or simulation studies shall be performed, as then the time speed-up becomes
obvious. The model can be easily specified, whereby the user does not need to know any
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Figure 12: Interactive prior specification window. The prior density is shown and can be
changed by sliding the bottom bars.
INLA-specific details. Quantities relevant in the field of diagnostic meta-regression are
internally computed and returned directly without requiring the user to work with the
general and complex INLA output.
One of the biggest advantages, besides of being fast, compared to other software pack-
ages for Bayesian inference is the flexible and at the same time intuitive prior specification
framework. In particular the newly proposed PC priors (Simpson et al., 2014) are sup-
ported. Here, the user has the possibility to incorporate expert knowledge in the form
of probability contrasts. Guo et al. (2015) compared the performance of different PC
priors with previous proposed priors in the bivariate model through an intensive simu-
lation study and a real data set. Both informative and less informative PC priors were
studied, and results indicated that the PC priors perform at least as good as previously
used priors.
A graphical user interface makes the package also attractive for users who prefer to
work with interactive windows offering selection menus. The GUI provides the full func-
tionality of the package. In addition the user can inspect the priors directly and change
them interactively. By offering fast inference within a Bayesian framework, intuitive
choice of prior distributions and the GUI we feel that this package has great potential for
routine practice. As a future research direction, we would like to expand the functional-
ity of this package to a three-variate model analysing sensitivity, specificity and disease
prevalence jointly. Further, we would like to investigate how to extend meta4diag when
the assumption of a perfect reference test is not given.
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Figure 13: Example of an SROC plot in the view area and the “SROC control panel” in
the left tool bar.
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